BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ismail R, Bocsik A, Katona G, Gróf I, Deli MA, Csóka I. Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability. Pharmaceutics 2019;11:E599. [PMID: 31726699 DOI: 10.3390/pharmaceutics11110599] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Akel H, Csóka I, Ambrus R, Bocsik A, Gróf I, Mészáros M, Szecskó A, Kozma G, Veszelka S, Deli MA, Kónya Z, Katona G. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin. Int J Mol Sci 2021;22:13258. [PMID: 34948054 DOI: 10.3390/ijms222413258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Kim H, Jang H, Cho H, Choi J, Hwang KY, Choi Y, Kim SH, Yang Y. Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy. Cancers (Basel) 2021;13:4435. [PMID: 34503245 DOI: 10.3390/cancers13174435] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
3 Akel H, Ismail R, Katona G, Sabir F, Ambrus R, Csóka I. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. Int J Pharm 2021;604:120724. [PMID: 34023443 DOI: 10.1016/j.ijpharm.2021.120724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Eissa NG, Elsabahy M, Allam A. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. Int J Pharm 2021;597:120317. [PMID: 33540005 DOI: 10.1016/j.ijpharm.2021.120317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Nie X, Chen Z, Pang L, Wang L, Jiang H, Chen Y, Zhang Z, Fu C, Ren B, Zhang J. Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds. Int J Nanomedicine 2020;15:10215-40. [PMID: 33364755 DOI: 10.2147/IJN.S285134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomedicine & Pharmacotherapy 2020;131:110708. [DOI: 10.1016/j.biopha.2020.110708] [Cited by in Crossref: 21] [Cited by in F6Publishing: 54] [Article Influence: 10.5] [Reference Citation Analysis]
7 Ismail R, Phan TNQ, Laffleur F, Csóka I, Bernkop-schnürch A. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. European Journal of Pharmaceutics and Biopharmaceutics 2020;152:10-7. [DOI: 10.1016/j.ejpb.2020.04.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
8 Kaplan MA, Sergienko KV, Kolmakova AA, Konushkin SV, Baikin AS, Kolmakov AG, Sevostyanov MA, Kulikov AV, Ivanov VE, Belosludtsev KN, Antipov SS, Volkov MY, Shusharina NN, Karaduleva EV, Kozlov VA, Simakin AV, Gudkov SV. Development of a Biocompatible PLGA Polymers Capable to Release Thrombolytic Enzyme Prourokinase. J Biomater Sci Polym Ed 2020;31:1405-20. [PMID: 32323635 DOI: 10.1080/09205063.2020.1760699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]